EW Healthcare Partners, L.P. 的 Form 4/A 修正申報
修正Venus Concept Inc.（VERO），2022/11/22 申報
- 申報編號
- 0000899243-22-036815
- 申報時間
- 2022/11/22 20:10 ET
- 交易日
- 2022/11/18
- 申報延遲
- 4 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
- 原始申報日
- 2022/11/22
這份申報列了 2 筆衍生性交易。交易後 4 天申報。
這份修正申報取代了 0000899243-22-036684（2022/11/22 申報）。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| EW Healthcare Partners, L.P.CIK 0001612343 | 持股 10% 以上大股東 |
| Essex Woodlands Fund IX-GP, L.P.CIK 0001652285 | 持股 10% 以上大股東 |
| Essex Woodlands IX, LLCCIK 0001652286 | 持股 10% 以上大股東 |
| EW Healthcare Partners-A, L.P.CIK 0001736240 | 持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
這份申報沒有這一類的交易。
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/11/18 | Common Stock | P買進取得 | +14,419,850 | $2.00 | +$2,883,970 | 1,441,985 | 間接 | 重複申報 |
| 2022/11/18 | Common Stock | P買進取得 | +580,150 | $2.00 | +$116,030 | 58,015 | 間接 | 重複申報 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The Voting Convertible Preferred Stock will convert into shares of Common Stock on a one for ten basis (i) at the option the holder or (ii) at the option of the Company within 30 days following the occurrence of certain events. The Voting Convertible Preferred Convertible Stock votes with the Common Stock on an as-converted basis. The Voting Convertible Preferred Stock does not expire.
- F2
Held by EW Healthcare Partners L.P. ("EWHP"). Essex Woodlands Fund IX-GP, L.P. ("EW Fund IX GP") is the general partner of EWHP and EWHP-A (as defined below). Essex Woodlands IX, LLC ("Essex IX General Partner") is the general partner of Essex IX Fund GP. Martin P. Sutter, R. Scott Barry, Ronald W. Eastman, Petri Vainio and Steve Wiggins are each a Manager of Essex IX General Partner (the "Managers"). Each of the Managers may be deemed to exercise shared voting and investment power with respect to such shares. Each of EW Fund IX GP, Essex IX General Partner and the Managers, including Mr. Barry who is a member of the Issuer's board of directors, disclaims beneficial ownership of the shares held by EWHP and EWHP-A, except to the extent of any pecuniary interests therein.
- F3
Held by EW Healthcare Partners-A.L.P. ("EWHP-A").
- F4
This Amended Form 4 is filed only to correct the Amount of Securities Underlying Derivative Security set forth in Box 7 of Table II in the original Form 4 filed on November 22, 2022 shown for EW Healthcare Partners, LP. from 14,410,850 to 14,419,850, and to correct the Suite number for the Reporting Persons' address to Suite 225. No other changes has been made to the original Form 4 filed on November 22, 2022 relating to the trade made on November 18, 2022.